Cancer Genomics and Proteomics : Impact Factor & More
eISSN: 1790-6245pISSN: 1109-6535
Share this on:
Key Metrics
CiteScore 
6.2
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q2Genetics
SNIP
0.94
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Cancer Genomics and Proteomics
Cancer Genomics and Proteomics Journal Specifications
| Overview | |
| Publisher | INT INST ANTICANCER RESEARCH |
| Language | English |
| Frequency | Bi-monthly |
| General Details |
View less
Planning to publish in Cancer Genomics and Proteomics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancer Genomics and Proteomics
Splicing Factor SF3B4 Promotes Melanoma Migration via Splicing-dependent Regulation of Talin1.
- 1 Mar 2026
- Cancer genomics & proteomics
Fibronectin 1 (FN1)-rearranged Mesenchymal Neoplasms: An Updated Review.
- 1 Mar 2026
- Cancer genomics & proteomics
NPM1 Drives ERK1/2-dependent Tumor Progression in Lung Cancer.
- 1 Mar 2026
- Cancer genomics & proteomics
γ-Glutamylcyclotransferase Depletion Induces p15INK4b and p21Cip1-mediated Senescence via TGF-β2/SMAD3 Pathway Activation in Breast Cancer Cells
- 1 Mar 2026
- Cancer Genomics & Proteomics
Co-expression of PKCζ and ALDH1A3 Is Associated With Poor Chemotherapeutic Responses in Basal-like Breast Cancer.
- 1 Mar 2026
- Cancer genomics & proteomics
Timescale-dependent Phosphoproteomic Remodeling and Motility-associated Adaptation under Chronic Cabozantinib Exposure in Renal Cell Carcinoma.
- 1 Mar 2026
- Cancer genomics & proteomics
Splicing Factor SF3B4 Promotes Melanoma Migration via Splicing-dependent Regulation of Talin1.
- 1 Mar 2026
- Cancer genomics & proteomics
Fibronectin 1 (FN1)-rearranged Mesenchymal Neoplasms: An Updated Review.
- 1 Mar 2026
- Cancer genomics & proteomics
NPM1 Drives ERK1/2-dependent Tumor Progression in Lung Cancer.
- 1 Mar 2026
- Cancer genomics & proteomics
γ-Glutamylcyclotransferase Depletion Induces p15INK4b and p21Cip1-mediated Senescence via TGF-β2/SMAD3 Pathway Activation in Breast Cancer Cells
- 1 Mar 2026
- Cancer Genomics & Proteomics
Co-expression of PKCζ and ALDH1A3 Is Associated With Poor Chemotherapeutic Responses in Basal-like Breast Cancer.
- 1 Mar 2026
- Cancer genomics & proteomics
Timescale-dependent Phosphoproteomic Remodeling and Motility-associated Adaptation under Chronic Cabozantinib Exposure in Renal Cell Carcinoma.
- 1 Mar 2026
- Cancer genomics & proteomics
FAQs on Cancer Genomics and Proteomics
How long has Cancer Genomics and Proteomics been actively publishing? 
What is the publishing frequency of Cancer Genomics and Proteomics?
How many articles did Cancer Genomics and Proteomics publish last year?
What is the eISSN & pISSN for Cancer Genomics and Proteomics?
What is Citescore for Cancer Genomics and Proteomics?
What is SNIP score for Cancer Genomics and Proteomics?
What is the SJR for Cancer Genomics and Proteomics?
Who is the publisher of Cancer Genomics and Proteomics?
